Show results for
Refine by
Ipsc Services In North America
7 services found
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Human iPSC-derived Microglia provide a reproducible, physiologically-relevant model in an easy-to-use, assay-ready format for investigating neuroglia involvement in neurodegeneration and neurodevelopment. We also offer a fully optimized serum-free Microglia Maintenance Medium to promote and support the maintenance of microglia. The method for generating ...
Manufactured by:Curi Bio based inSeattle, WASHINGTON (USA)
Curi Bio’s iPSC Repositories Available for Services. Custom Panel of Different Gender and Ethnicities. Disease Model Pairs. Patient-derived iPSC-lines. Isogenic DMD/WT Myoblasts. Isogenic DMD/WT ...
Manufactured by:Vascugen Inc. based inMadison, WISCONSIN (USA)
By doing so we mitigate technology and tech transfer risks along the development chain. Embedded within our R&D facility is a state-of-the-art cleanroom designed to iPSC industry standards. Dedicated quality assurance (QA) and a quality management system (eQMS) are in place for compliance and product release. Where feasible, we deploy closed system manufacturing platforms in ...
Manufactured by:Curi Bio based inSeattle, WASHINGTON (USA)
Curi Bio has a repository of iPSC’s for disease modeling and proprietary technologies for differentiating these cells into myoblasts and cardiomyocytes. Curi has developed in vitro 3D disease models for multiple disease phenotypes. In addition, Curi has the capability of generating new gene-edited iPSC models in ...
by:Lena Biosciences, Inc. based inAtlanta, GEORGIA (US) (USA)
We routinely run assays with primary cells and iPSC-derived cells. Organ models: liver, brain, blood and tumors. Normal tissue models: 3D cell-based culture and co-culture models. Tumors: lung, breast, liver etc. We can test small molecules and biologics with tissue slices, and organoids, and maintain cell diversity in the unaltered patient tissue. ...
by:Cell Manufacturing Technologies (CMaT) based inAtlanta, GEORGIA (US) (USA)
Specifially, three Engineered Systems (Test-Beds) are envisioned: Mesenchymal Stem/Stromal Cells (MSCs) to repair, regenerate, and restore diseased tissues and organs. T cell immunotherapies to cure cancer. Induced Pluripotent Stem Cell-derived cardiac cells (iPSC-CM) to treat heart diseases. In each of these Test-Beds, CMaT will focus on three, synergistic technical innovation ...
Manufactured by:Regenerative Medical Solutions Inc. (RMS) based inMadison, WISCONSIN (USA)
RMS produces human induced pluripotent stem cell derived Islet-Like Clusters (ILC) for dual research tool and therapeutic use targeting diabetes. ILC were developed after over 15 years of research at the University of Wisconsin-Madison in the lab of world renowned researcher, Dr. Jon Odorico, MD, FACS and have undergone eight additional years of further research at RMS. This has resulted in ...